What amount sold does DERMAMEDICS LLC report in Form D filings?

The latest linked filings report $970K sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was DERMAMEDICS LLC's most recent SEC filing?

DERMAMEDICS LLC's most recent Form D filing was on 2013-04-22.

What type of securities does DERMAMEDICS LLC offer?

DERMAMEDICS LLC's SEC Form D filings indicate debt offerings.

DERMAMEDICS LLC

CIK: 0001539684·Pharmaceuticals·OKLAHOMA CITY, OK·Limited Liability Company·Founded 2010

Reported Sold

$970,000

Total Filings

Identified Offerings

Last Filed

Apr 22, 2013

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pharmaceuticals industry

SEC EDGAR

Offering filing timeline

Apr 22, 2013Form D — New notice

Reported sold: $0 · Target: $1,000,000

Rule 506·0 investors

Feb 1, 2012Form D — New notice

Reported sold: $970,000 · Target: $1,500,000

Rule 506·9 investors

Fundraising Profile

Exemptions

Rule 506

Investors in latest filing

Revenue Range

$1 - $1,000,000

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 2 identified offerings

$970,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Bryan Fuller

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Apr 22, 2013	New	$1,000,000	$0	0
Feb 1, 2012	New	$1,500,000	$970,000	9

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Telemachus Therapeutics, Inc.

Pharmaceuticals

Offering target: $1,500,000

Filed Oct 28, 2026